“Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial.”, Pract Radiat Oncol, vol. 10, no. 2, pp. e82-e90, 2020.
, ,
“Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery.”, BJU Int, vol. 115, no. 3, pp. 419-29, 2015.
,